Concepedia

Jeff Jorgensen

JJ

5

Publications

516

Citations

5

H-Index

2011

Active since

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

University of California, San Francisco

Jeff Jorgensen is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, hematology, and oncology.

Top concepts

Publications per year

2011–2022

5

Publications

5

COL4A2 Mutations Impair COL4A1 and COL4A2 Secretion and Cause Hemorrhagic Stroke

Marion Jeanne, Cassandre Labelle‐Dumais, Jeff Jorgensen et al. · The American Journal of Human Genetics · 2011 · 218 citations · Full text

, , +4

Molecular and Genetic Analyses of Collagen Type IV Mutant Mouse Models of Spontaneous Intracerebral Hemorrhage Identify Mechanisms for Stroke Prevention

Marion Jeanne, Jeff Jorgensen, Douglas B. Gould · Circulation · 2015 · 143 citations · Full text

Pre-transplantation minimal residual disease with cytogenetic and molecular diagnostic features improves risk stratification in acute myeloid leukemia

Betül Oran, Jeff Jorgensen, David Marín et al. · Haematologica · 2016 · 65 citations · Full text

, , +19

Ibrutinib–rituximab followed by R-HCVAD as frontline treatment for young patients (≤65 years) with mantle cell lymphoma (WINDOW-1): a single-arm, phase 2 trial

Michael Wang, Preetesh Jain, Shuangtao Zhao et al. · The Lancet Oncology · 2022 · 54 citations · Full text

, , +9

Serial minimal residual disease (MRD) monitoring during first-line FCR treatment for CLL may direct individualized therapeutic strategies

Philip A. Thompson, Christine B. Peterson, Paolo Strati et al. · Leukemia · 2018 · 36 citations · Full text

, , +5

Rows per page

1–5 of 5